The Effect of Cognitive-Behavioral Training Combined with Motivational Interviewing on Depression Severity in Patients with Diabetes and Depressive Symptoms

Abstract

Aims: to examine the effect of cognitive-behavioral training combined with motivational interviewing on severty of depression in patients with diabetes and depressive symptoms. Methods: This clinical trial was performed on two groups of 45 patients (n = 90) with type 2 diabetes and depression in a diabetes clinic affiliated with a teaching hospital in Iran in 2021. The participants were selected using convenience sampling and randomly divided into two intervention groups. The patients in the cognitive-behavioral intervention group with motivational interviewing attended 8 face-to-face training sessions 3 times a week, and the patients in the cognitive-behavioral group attended only 4 cognitive-behavioral training sessions 2 times a week. Twelve weeks after the intervention, the severty of depression symptoms were collected using Beck Depression Inventory (BDI). The collected data were analyzed with SPSS software (version 22) using paired samples t-test, independent samples t-test and chi-square. Results: The results showed that before the intervention there was no difference between the two groups in terms of mean depression score (p=0.54).But after receiving the intervention the mean and standard deviation of depression score of the patients in the group receiving cognitive-behavioral training combined with motivational interviewing (20.24±4.40) were significantly lower than the corresponding values for the patients in the cognitive-behavioral training group (24.62±4.26, p = 0.001). Conclusion: Cognitive-behavioral training combined with motivational interviewing had a greater effect on decreasing depression Severity in patients with diabetes and depression compared to cognitive-behavioral training alone. Thus, motivational approaches can be incorporated into routine psychological training to better manage diabetes and depression symptoms. Trial Registration Details: This study was a clinical trial approved with the code IRCT20160924029954N14. Funding Information: This study did not receive any specific grant from the funding agencies in the public, commercial, or not-for-profit sectors. Declaration of Interests: The authors declare no conflicts of interest in this study. Ethics Approval Statement: This study was approved by the Ethics Committee of Zahedan University of Medical Siences with the Ethic code of IR.ZAUMS.REC.1399.190.